USD 0.01
(-11.97%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -4.25 Million | -2.92 Million | -3.68 Million | -1.22 Million | -1.17 Million | -955.32 Thousand |
Net Income | -6.37 Million | -1.39 Million | -4.37 Million | -2.82 Million | -2.39 Million | -4.7 Million |
Depreciation & Amortization | 648.45 Thousand | 530.88 Thousand | 437.59 Thousand | 472.29 Thousand | 530.39 Thousand | 758.99 Thousand |
Deferred income taxes | - | -2.45 Million | -2733.00 | 150.55 Thousand | -279.7 Thousand | 1.44 Million |
Stock-based compensation | 569.47 | 346.65 Thousand | 960.23 Thousand | 3610.00 | 328.56 Thousand | 628.81 Thousand |
Change in working capital | -281.27 Thousand | 73.82 Thousand | -715.81 Thousand | 384.68 Thousand | -100.61 Thousand | 185.93 Thousand |
Other non-cash items | 3.06 Million | -33.55 Thousand | 13.42 Thousand | 592.6 Thousand | 744.01 Thousand | 734.35 Thousand |
Investing Cash Flow | -1.68 Million | -4.16 Million | -1.3 Million | -694.74 Thousand | -1.37 Million | -1.36 Million |
Investments in PPE | -1.44 Million | -1.71 Million | -1.33 Million | -167.07 Thousand | -121.93 Thousand | -54.88 Thousand |
Acquisitions | 718.00 | 42.39 Thousand | 34.09 Thousand | -480.72 Thousand | -1.25 Million | -1.31 Million |
Investment purchases | -244.6 Thousand | -500 Thousand | - | -532.66 Thousand | -1.25 Million | -1.31 Million |
Sales/Maturities of investments | - | -42.39 Thousand | - | 532.66 Thousand | - | - |
Other Investing Activities | 718.00 | -1.95 Million | 34.09 Thousand | -46.94 Thousand | 1.25 Million | 600.00 |
Financing Cash Flow | 4.72 Million | 5.11 Million | 8.01 Million | 2.28 Million | 677.91 Thousand | 3.76 Million |
Debt repayment | -2.27 Million | -1.56 Million | -348.25 Thousand | -349.85 Thousand | -380.69 Thousand | -109.28 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 2.61 Million | 5.2 Million | 6.04 Million | 880.5 Thousand | - | 3.52 Million |
Other Financing Activities | 395.00 | 1.47 Million | 2.32 Million | 1.74 Million | 1.05 Million | 3.87 Million |
Accounts receivables | -11.99 Thousand | 20 Thousand | -95.21 Thousand | 271.82 Thousand | -109.3 Thousand | 186.07 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -269.27 Thousand | 53.81 Thousand | -620.6 Thousand | 112.85 Thousand | 8684.00 | -134.00 |
Cash at beginning of period | 1.52 Million | 3.55 Million | 520.19 Thousand | 154.76 Thousand | 2.02 Million | 583.39 Thousand |
Cash at end of period | 304.65 Thousand | 1.57 Million | 3.55 Million | 520.19 Thousand | 154.76 Thousand | 2.02 Million |
Capital Expenditure | -1.44 Million | -1.71 Million | -1.33 Million | -167.07 Thousand | -121.93 Thousand | -54.88 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.21 Million | -1.98 Million | 3.03 Million | 365.43 Thousand | -1.87 Million | 1.44 Million |
Free Cash Flow | -5.69 Million | -4.64 Million | -5.01 Million | -1.38 Million | -1.29 Million | -1.01 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.35 Million | -1.36 Million | -1.78 Million | -6.37 Million | -1.96 Million | -1.28 Million |
Depreciation & Amortization | 161.65 Thousand | 159.67 Thousand | 160.78 Thousand | 648.45 Thousand | 153.91 Thousand | 181.24 Thousand |
Deferred income taxes | - | - | - | - | -733.68 Thousand | 19.37 Thousand |
Stock-based compensation | 43.67 | 64.86 | 65.92 Thousand | 569.46 Thousand | 413.56 Thousand | 36.37 Thousand |
Change in working capital | -119.78 Thousand | -51.92 Thousand | -75.57 Thousand | -281.27 Thousand | 192.36 Thousand | -136.79 Thousand |
Other non-cash items | 510.37 Thousand | 557.17 Thousand | 1.02 Million | 3.06 Million | 931.62 Thousand | -303.00 |
Investing Cash Flow | -160.35 Thousand | -167.28 Thousand | -419.16 Thousand | -1.68 Million | -190.34 Thousand | -669.05 Thousand |
Investments in PPE | -106.47 Thousand | -123.82 Thousand | -175.27 Thousand | -1.44 Million | -190.34 Thousand | -669.05 Thousand |
Acquisitions | -53.88 Thousand | -43.46 | 718.00 | 718.00 | - | - |
Investment purchases | -53.88 Thousand | -43.46 Thousand | -244.6 Thousand | -244.6 Thousand | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -106.47 Thousand | - | -243.89 | 718.00 | - | - |
Financing Cash Flow | 2.61 Million | 992.74 Thousand | 1.7 Million | 4.72 Million | 935.67 Thousand | 2.1 Million |
Debt repayment | -1.06 Million | -790.84 Thousand | -675.65 Thousand | -2.27 Million | -2.95 Million | -35.24 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 2.88 Million | 250 Thousand | 2.45 Million | 2.61 Million | 160 Thousand | - |
Other Financing Activities | 860.01 Thousand | 60.00 | 1708.00 | 395.00 | 3.72 Million | 2.14 Million |
Accounts receivables | 17.44 Thousand | -30.39 Thousand | -14.2 Thousand | -11.99 Thousand | -12.3 Thousand | -2729.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -137.22 Thousand | -21.52 Thousand | -61.37 Thousand | -269.27 Thousand | 204.66 Thousand | -134.06 Thousand |
Cash at beginning of period | 81.18 Thousand | 304.65 Thousand | 80.21 Thousand | 1.52 Million | 343.42 Thousand | 89.84 Thousand |
Cash at end of period | 1.42 Million | 81.18 Thousand | 304.65 Thousand | 304.65 Thousand | 80.21 Thousand | 343.42 Thousand |
Capital Expenditure | -106.47 Thousand | -123.82 Thousand | -175.27 Thousand | -1.44 Million | -190.34 Thousand | -669.05 Thousand |
Effect of forex changes on cash | - | - | - | - | - | 1.00 |
Net cash flow / Change in cash | 1.34 Million | -223.47 Thousand | 224.43 Thousand | -1.21 Million | -263.2 Thousand | 253.57 Thousand |
Free Cash Flow | -1.21 Million | -1.17 Million | -1.18 Million | -5.69 Million | -1.19 Million | -1.85 Million |
CTS
9936
S
SO
BIOGF
1023